Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 159847-71-9 | MDL No. : | MFCD20640420 |
Formula : | C8H6N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VEDDRDQNFWIJHM-UHFFFAOYSA-N |
M.W : | 162.15 | Pubchem ID : | 10261390 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 42.52 |
TPSA : | 87.11 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.52 cm/s |
Log Po/w (iLOGP) : | 0.81 |
Log Po/w (XLOGP3) : | 1.08 |
Log Po/w (WLOGP) : | 0.85 |
Log Po/w (MLOGP) : | -0.72 |
Log Po/w (SILICOS-IT) : | 0.47 |
Consensus Log Po/w : | 0.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.83 |
Solubility : | 2.4 mg/ml ; 0.0148 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.5 |
Solubility : | 0.511 mg/ml ; 0.00315 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.49 |
Solubility : | 5.27 mg/ml ; 0.0325 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.4 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | at 20 - 100℃; for 15 h; | To a solution of 3-amino-4-bromo-benzoic acid (6.0 g, 276 mmol) in dimethyl formamide (30 ml), was added sequentially at ambient temperature zinc cyanide (11.66 g, 99.4 mmol) and tetrakis(triphenylphosphine)palladium (9.57 g, 8.28 mmol). The mixture was heated to 100°C for 14 hours. The reaction mixture was allowed to cool to <n="29"/>ambient temperature before the sequential addition of more zinc cyanide (0.65 g, 5.54 mmol) and tetrakis(triphenylphosphine)palladium (1.9 g, 1.64 mmol) at ambient temperature. The mixture was heated to 1000C for 1 more hour. The reaction mixture was allowed to cool to ambient temperature and was quenched by addition of a mixture of toluene and aqueous ammonia (IM). The phases were separated and the aqueous layer was extracted with toluene. The combined organic phases were dried over sodium sulfate and concentrated. The residue was purified by column chromatography on silica gel (eluent: ethyl acetate / cyclohexane 1:2 to 1 :0) to give 3-amino-4-cyano-benzoic acid (2.94 g, 67percent yield). |
[ 159847-80-0 ]
Methyl 4-amino-3-cyanobenzoate
Similarity: 0.90
[ 159847-83-3 ]
Methyl 2-amino-4-cyanobenzoate
Similarity: 0.87
[ 159847-80-0 ]
Methyl 4-amino-3-cyanobenzoate
Similarity: 0.90
[ 159847-83-3 ]
Methyl 2-amino-4-cyanobenzoate
Similarity: 0.87
[ 159847-80-0 ]
Methyl 4-amino-3-cyanobenzoate
Similarity: 0.90
[ 159847-83-3 ]
Methyl 2-amino-4-cyanobenzoate
Similarity: 0.87
[ 199536-01-1 ]
Methyl 3-amino-5-cyanobenzoate
Similarity: 0.85